NEW YORK (GenomeWeb News) – Febit has joined a European consortium focused on developing DNA sequencing technologies, and plans to advance its gene capturing technology for use with the group's members.
The Revolutionary Approaches and Devices for Nucleic Acid analysis consortium, involving 16 industry and academic research entities and funded by the European Union with €12 million ($15.1 million), is focused on developing faster, more cost-efficient and targeted approaches in comparative genomics.
The HybSelect technology enables capture of specific DNA regions for high-throughput sequencing, allows researchers to operate next-generation sequencers by directing the sequencing process to the regions of interest to the researcher, Febit CSO Peer Stähler said in a statement.